Chemical Compound Review:
Accolate cyclopentyl N-[3-[[2-methoxy-4-[(2...
Synonyms:
Accoleit, Aeronix, Olmoran, Zafirst, Respix, ...
- Zafirlukast and Churg-Strauss syndrome. Katz, R.S., Papernik, M. JAMA (1998)
- Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. Wechsler, M.E., Garpestad, E., Flier, S.R., Kocher, O., Weiland, D.A., Polito, A.J., Klinek, M.M., Bigby, T.D., Wong, G.A., Helmers, R.A., Drazen, J.M. JAMA (1998)
- Severe liver injury after treatment with the leukotriene receptor antagonist zafirlukast. Reinus, J.F., Persky, S., Burkiewicz, J.S., Quan, D., Bass, N.M., Davern, T.J. Ann. Intern. Med. (2000)
- The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. Bagenstose, S.E., Levin, L., Bernstein, J.A. J. Allergy Clin. Immunol. (2004)
- Summary of clinical trials with zafirlukast. Calhoun, W.J. Am. J. Respir. Crit. Care Med. (1998)
- Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma. Adkins, J.C., Brogden, R.N. Drugs (1998)
- Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals. Jain, N.K., Kulkarni, S.K., Singh, A. Eur. J. Pharmacol. (2001)
- Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Hui, K.P., Barnes, N.C. Lancet (1991)
- New approaches to anti-inflammatory therapy for asthma. Wenzel, S.E. Am. J. Med. (1998)
- Leukotriene E(4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma. Laitinen, A., Lindqvist, A., Halme, M., Altraja, A., Laitinen, L.A. J. Allergy Clin. Immunol. (2005)
- Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Green, R.L., Vayonis, A.G. Lancet (1999)
- Inhibition of 5-lipoxygenase diminishes neurally evoked tachykinergic contraction of guinea pig isolated airway. McAlexander, M.A., Myers, A.C., Undem, B.J. J. Pharmacol. Exp. Ther. (1998)
- Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers. Sheftell, F., Rapoport, A., Weeks, R., Walker, B., Gammerman, I., Baskin, S. Headache. (2000)
- Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. Bonadonna, P., Lombardi, C., Senna, G., Canonica, G.W., Passalacqua, G. J. Am. Acad. Dermatol. (2003)
- Failure of zafirlukast to prevent ibuprofen-induced anaphylaxis. Menendez, R., Venzor, J., Ortiz, G. Ann. Allergy Asthma Immunol. (1998)
- The effect of zafirlukast on repetitive exercise-induced bronchoconstriction: the possible role of leukotrienes in exercise-induced refractoriness. Dessanges, J.F., Préfaut, C., Taytard, A., Matran, R., Naya, I., Compagnon, A., Dinh-Xuan, A.T. J. Allergy Clin. Immunol. (1999)
- Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Virchow, J.C., Prasse, A., Naya, I., Summerton, L., Harris, A. Am. J. Respir. Crit. Care Med. (2000)
- Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Roquet, A., Dahlén, B., Kumlin, M., Ihre, E., Anstrén, G., Binks, S., Dahlén, S.E. Am. J. Respir. Crit. Care Med. (1997)
- A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma. Ravasi, S., Capra, V., Mezzetti, M., Nicosia, S., Rovati, G.E. Mol. Pharmacol. (2000)
- Expression of functional cysteinyl leukotriene receptors by human basophils. Gauvreau, G.M., Plitt, J.R., Baatjes, A., MacGlashan, D.W. J. Allergy Clin. Immunol. (2005)
- Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Sampson, A.P., Siddiqui, S., Buchanan, D., Howarth, P.H., Holgate, S.T., Holloway, J.W., Sayers, I. Thorax (2000)
- An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways. Buckner, C.K., Fedyna, J.S., Robertson, J.L., Will, J.A., England, D.M., Krell, R.D., Saban, R. J. Pharmacol. Exp. Ther. (1990)
- Zafirlukast metabolism by cytochrome P450 3A4 produces an electrophilic alpha,beta-unsaturated iminium species that results in the selective mechanism-based inactivation of the enzyme. Kassahun, K., Skordos, K., McIntosh, I., Slaughter, D., Doss, G.A., Baillie, T.A., Yost, G.S. Chem. Res. Toxicol. (2005)
- Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Sarau, H.M., Ames, R.S., Chambers, J., Ellis, C., Elshourbagy, N., Foley, J.J., Schmidt, D.B., Muccitelli, R.M., Jenkins, O., Murdock, P.R., Herrity, N.C., Halsey, W., Sathe, G., Muir, A.I., Nuthulaganti, P., Dytko, G.M., Buckley, P.T., Wilson, S., Bergsma, D.J., Hay, D.W. Mol. Pharmacol. (1999)
- Inhibition of leukotriene D4-induced bronchoconstriction in subjects with asthma: a concentration-effect study of ICI 204,219. Smith, L.J., Glass, M., Minkwitz, M.C. Clin. Pharmacol. Ther. (1993)
- Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma. Busse, W., Nelson, H., Wolfe, J., Kalberg, C., Yancey, S.W., Rickard, K.A. J. Allergy Clin. Immunol. (1999)
- Influence of zafirlukast and loratadine on exercise-induced bronchoconstriction. Dahlén, B., Roquet, A., Inman, M.D., Karlsson, O., Naya, I., Anstrén, G., O'Byrne, P.M., Dahlén, S.E. J. Allergy Clin. Immunol. (2002)
- Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma. Jarvis, B., Faulds, D. Drugs (1999)
- Pharmacokinetic profile of zafirlukast. Dekhuijzen, P.N., Koopmans, P.P. Clinical pharmacokinetics. (2002)
- Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors. Jaakkola, T., Laitila, J., Neuvonen, P.J., Backman, J.T. Basic & clinical pharmacology & toxicology. (2006)
- Inhibition of human cytochrome P450 isoforms in vitro by zafirlukast. Shader, R.I., Granda, B.W., von Moltke, L.L., Giancarlo, G.M., Greenblatt, D.J. Biopharmaceutics & drug disposition. (1999)
- Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Drazen, J. Am. J. Respir. Crit. Care Med. (1998)
- The effect of the oral leukotriene antagonist, ICI 204,219, on leukotriene D4 and histamine-induced cutaneous vascular reactions in man. Bernstein, J.A., Greenberger, P.A., Patterson, R., Glass, M., Krell, R., Thyrum, P.T. J. Allergy Clin. Immunol. (1991)
- Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge. Calhoun, W.J., Lavins, B.J., Minkwitz, M.C., Evans, R., Gleich, G.J., Cohn, J. Am. J. Respir. Crit. Care Med. (1998)
- An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses. Tashkin, D.P., Nathan, R.A., Howland, W.C., Minkwitz, M.C., Simonson, S.G., Bonuccelli, C.M. J. Allergy Clin. Immunol. (1999)